STENTYS to Present First Results of Sirolimus-Eluting Self-Apposing(R) Stent ... Wall Street Journal STENTYS (FR0010949404 -- STNT), a medical technology company commercializing the world's first and only Self-Apposing(R) Stent to treat acute myocardial infarction (AMI), today announced that the 4-month results of the APPOSITION IV trial will be ... |
